• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压的基因组学决定因素研究——重点关注代谢组学和肠道微生物组。

Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

机构信息

Department of Twin Research, King's College London, London, UK.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

出版信息

Am J Hypertens. 2020 May 21;33(6):473-481. doi: 10.1093/ajh/hpaa022.

DOI:10.1093/ajh/hpaa022
PMID:32060494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7241940/
Abstract

Epidemiologic and genomic studies have progressively improved our understanding of the causation of hypertension and the complex relationship with diet and environment. The majority of Mendelian forms of syndromic hypotension and hypertension (HTN) have all been linked to mutations in genes whose encoded proteins regulate salt-water balance in the kidney, supporting the primacy of the kidneys in blood pressure regulation. There are more than 1,477 single nucleotide polymorphisms associated with blood pressure and hypertension and the challenge is establishing a causal role for these variants. Hypertension is a complex multifactorial phenotype and it is likely to be influenced by multiple factors including interactions between diet and lifestyle factors, microbiome, and epigenetics. Given the finite genetic variability that is possible in humans, it is likely that incremental gains from single marker analyses have now plateaued and a greater leap in our understanding of the genetic basis of disease will come from integration of other omics and the interacting environmental factors. In this review, we focus on emerging results from the microbiome and metabolomics and discuss how leveraging these findings may facilitate a deeper understanding of the interrelationships between genomics, diet, and microbial ecology in humans in the causation of essential hypertension.

摘要

流行病学和基因组学研究逐渐提高了我们对高血压病因以及其与饮食和环境之间复杂关系的认识。大多数综合征性低血压和高血压(HTN)的孟德尔形式都与调节肾脏盐水平衡的基因的突变有关,这支持了肾脏在血压调节中的首要地位。有超过 1477 个单核苷酸多态性与血压和高血压相关,挑战在于确定这些变体的因果作用。高血压是一种复杂的多因素表型,它可能受到多种因素的影响,包括饮食和生活方式因素、微生物组和表观遗传学之间的相互作用。鉴于人类可能存在的有限遗传可变性,单标记分析的增量收益可能已经达到顶峰,而对疾病遗传基础的理解的更大飞跃将来自于整合其他组学和相互作用的环境因素。在这篇综述中,我们重点介绍了微生物组和代谢组学的新成果,并讨论了如何利用这些发现来促进对人类基因组学、饮食和微生物生态学之间相互关系的深入理解,从而更好地了解原发性高血压的病因。

相似文献

1
Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.高血压的基因组学决定因素研究——重点关注代谢组学和肠道微生物组。
Am J Hypertens. 2020 May 21;33(6):473-481. doi: 10.1093/ajh/hpaa022.
2
Missing Heritability of Hypertension and Our Microbiome.高血压的遗传力缺失与我们的微生物组
Circulation. 2018 Oct 2;138(14):1381-1383. doi: 10.1161/CIRCULATIONAHA.118.036224.
3
Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension.《基础与实验性高血压中肠道微生物组研究透明度指南》
Hypertension. 2019 Dec;74(6):1279-1293. doi: 10.1161/HYPERTENSIONAHA.119.13079. Epub 2019 Nov 4.
4
Integration of genomics, metagenomics, and metabolomics to identify interplay between susceptibility alleles and microbiota in adenoma initiation.整合基因组学、宏基因组学和代谢组学,以鉴定易感性等位基因与腺瘤起始过程中的微生物组之间的相互作用。
BMC Cancer. 2020 Jun 29;20(1):600. doi: 10.1186/s12885-020-07007-9.
5
Polygenic Interactions With Environmental Exposures in Blood Pressure Regulation: The HUNT Study.多基因相互作用与血压调节中的环境暴露:HUNT 研究。
J Am Heart Assoc. 2024 Oct;13(19):e034612. doi: 10.1161/JAHA.123.034612. Epub 2024 Sep 18.
6
The emerging role of gut microbial metabolism on cardiovascular disease.肠道微生物代谢在心血管疾病中的新兴作用。
Curr Opin Microbiol. 2019 Aug;50:64-70. doi: 10.1016/j.mib.2019.09.007. Epub 2019 Nov 3.
7
Omics in gut microbiome analysis.肠道微生物组分析中的组学。
J Microbiol. 2021 Mar;59(3):292-297. doi: 10.1007/s12275-021-1004-0. Epub 2021 Feb 23.
8
Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.营养基因组学、微生物组与基因-环境相互作用:心血管疾病研究、预防和治疗的新方向:美国心脏协会科学声明
Circ Cardiovasc Genet. 2016 Jun;9(3):291-313. doi: 10.1161/HCG.0000000000000030. Epub 2016 Apr 19.
9
The Interplay of Diet, Genome, Metabolome, and Gut Microbiome in Cardiovascular Disease: A Narrative Review.饮食、基因组、代谢组和肠道微生物群在心血管疾病中的相互作用:一篇叙述性综述。
Curr Med Chem. 2025 Jan 6. doi: 10.2174/0109298673342364241119114722.
10
Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases.肠道微生物组及其宏基因组学观点:对心血管疾病的深远影响。
Gut Microbes. 2021 Jan-Dec;13(1):1936379. doi: 10.1080/19490976.2021.1936379.

引用本文的文献

1
Personalized Nutrition Biomarkers and Dietary Strategies for Atherosclerosis Risk Management: A Systematic Review.用于动脉粥样硬化风险管理的个性化营养生物标志物和饮食策略:一项系统综述
Nutrients. 2025 Aug 28;17(17):2804. doi: 10.3390/nu17172804.
2
Molecular Mechanisms and Emerging Precision Therapeutics in the Gut Microbiota-Cardiovascular Axis.肠道微生物群-心血管轴的分子机制与新兴精准疗法
Cureus. 2025 Apr 26;17(4):e83022. doi: 10.7759/cureus.83022. eCollection 2025 Apr.
3
Identification of serum metabolic markers in non-obese hypertensive patients using non-targeted metabolomics.使用非靶向代谢组学鉴定非肥胖高血压患者的血清代谢标志物
Sci Rep. 2025 May 26;15(1):18320. doi: 10.1038/s41598-025-02162-0.
4
Blood L-cystine levels positively related to increased risk of hypertension.血液中L-胱氨酸水平与高血压风险增加呈正相关。
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1411-1423. doi: 10.1111/jch.14902. Epub 2024 Oct 15.
5
Nasal turbinate lymphatic obstruction: a proposed new paradigm in the etiology of essential hypertension.鼻甲骨淋巴管阻塞:原发性高血压病因学中一种新提出的范式。
Front Med (Lausanne). 2024 Aug 16;11:1380632. doi: 10.3389/fmed.2024.1380632. eCollection 2024.
6
Gut microbiota: a potential new regulator of hypertension.肠道微生物群:高血压的一种潜在新调节因子。
Front Cardiovasc Med. 2024 Jun 27;11:1333005. doi: 10.3389/fcvm.2024.1333005. eCollection 2024.
7
Updates in the management of hypertension.高血压管理的进展
Ann Med Surg (Lond). 2024 Apr 23;86(6):3514-3521. doi: 10.1097/MS9.0000000000002052. eCollection 2024 Jun.
8
Natural Product Co-Metabolism and the Microbiota-Gut-Brain Axis in Age-Related Diseases.天然产物共代谢与衰老相关疾病中的微生物群-肠-脑轴
Life (Basel). 2022 Dec 23;13(1):41. doi: 10.3390/life13010041.
9
A Preliminary Study on the Value of Intestinal Flora in Predicting Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Refractory Hypertension.肠道菌群预测难治性高血压患者主要不良心脑血管事件价值的初步研究。
Comput Math Methods Med. 2022 Aug 24;2022:7723105. doi: 10.1155/2022/7723105. eCollection 2022.
10
Genetic Modifications to Alter Blood Pressure Level.改变血压水平的基因修饰
Biomedicines. 2022 Aug 1;10(8):1855. doi: 10.3390/biomedicines10081855.

本文引用的文献

1
Metabolomic profiles associated with all-cause mortality in the Women's Health Initiative.与妇女健康倡议全因死亡率相关的代谢组学特征。
Int J Epidemiol. 2020 Feb 1;49(1):289-300. doi: 10.1093/ije/dyz211.
2
Diet-microbiota interactions and personalized nutrition.饮食-微生物群相互作用与个性化营养。
Nat Rev Microbiol. 2019 Dec;17(12):742-753. doi: 10.1038/s41579-019-0256-8. Epub 2019 Sep 20.
3
Gut Microbiome and Response to Cardiovascular Drugs.肠道微生物组与心血管药物反应。
Circ Genom Precis Med. 2019 Sep;12(9):421-429. doi: 10.1161/CIRCGEN.119.002314. Epub 2019 Aug 28.
4
Protective Effects of Dietary MUFAs Mediating Metabolites against Hypertension Risk in the Korean Genome and Epidemiology Study.膳食 MUFA 介导的代谢物对韩国基因组与流行病学研究中高血压风险的保护作用。
Nutrients. 2019 Aug 16;11(8):1928. doi: 10.3390/nu11081928.
5
Differential Analysis of Hypertension-Associated Intestinal Microbiota.高血压相关肠道微生物组的差异分析。
Int J Med Sci. 2019 Jun 2;16(6):872-881. doi: 10.7150/ijms.29322. eCollection 2019.
6
Primary Aldosteronism.原发性醛固酮增多症
Hypertension. 2019 Sep;74(3):458-466. doi: 10.1161/HYPERTENSIONAHA.119.12935. Epub 2019 Jul 22.
7
Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites.健康受试者微生物组和代谢组的多组学分析揭示了饮食与代谢物之间依赖微生物组的关系。
Front Genet. 2019 May 17;10:454. doi: 10.3389/fgene.2019.00454. eCollection 2019.
8
Clinical and Molecular Perspectives of Monogenic Hypertension.单基因高血压的临床与分子视角
Curr Hypertens Rev. 2020;16(2):91-107. doi: 10.2174/1573402115666190409115330.
9
The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?饮食对高血压病理的影响:是否存在通过肠道微生物群驱动的免疫代谢的关联?
Cardiovasc Res. 2019 Jul 1;115(9):1435-1447. doi: 10.1093/cvr/cvz091.
10
Gut Microbiota Composition and Blood Pressure.肠道微生物组成与血压。
Hypertension. 2019 May;73(5):998-1006. doi: 10.1161/HYPERTENSIONAHA.118.12109.